Research Article
Integron-Mediated Antibiotic Resistance in Acinetobacter baumannii Isolated from Intensive Care Unit Patients, Babol, North of Iran
Table 2
Bacterial etiologic agents.
| Agents | All BALs | Mono (%) | Poly (%) | Total (%) |
| A. baumannii | 30 (41.1%) | 5 (6.8%) | 35 (48%) | Pseudomonas aeruginosa | 3 (4.1%) | 1 (1.9%) | 4 (5.5%) | Staphylococcus aureus | 2 (2.7%) | 2 (2.7%) | 4 (5.5%) | Klebsiella pneumoniae | 1 (1.4%) | 0 (0.0%) | 1 (1.4%) | Escherichia coli | 0 (0.0%) | 1 (1.4%) | 1 (1.4%) | Enterobacter cloacae | 0 (0.0%) | 1 (1.4%) | 1 (1.4%) | Serratia marcescens | 0 (0.0%) | 2 (2.7%) | 2 (2.7%) | Stenotrophomonas maltophilia | 1 (1.4%) | 0 (0.0%) | 1 (1.4%) | MRCoNS | 1 (1.4%) | 0 (0.0%) | 1 (1.4%) | Streptococcus pneumoniae | 2 (2.7%) | 0 (0.0%) | 2 (2.7%) |
|
|
Mono = unique isolated agent; Poly = polymicrobial infection; MRCoNS = methicillin resistant coagulase-negative Staphylococcus.
|